Search Medical Condition
Please enter condition
Please choose location from dropdown

Lung Cancer Clinical Trials

A listing of Lung Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (2144) clinical trials

This is an open-label, randomized (1:1), multicenter, Phase 3 clinical trial evaluating the safety and efficacy of nivolumab in combination with investigational agent sitravatinib compared to docetaxel in patients with advanced non-squamous NSCLC who have previously experienced radiographic disease progression on or after treatment with platinum-based chemotherapy in combination with ...

Phase

- This is the first study where BAY1163877 is given to humans. Impact of the study is to evaluate if patients with advanced solid cancers show advanced clinical benefit under the treatment with the pan FGFR inhibitor. Patients (all comers) will receive the study drug treatment in a dose-escalation scheme ...

Phase

A research study is evaluating an investigational pneumonia vaccine compared to an FDA-approved comparator vaccine.  

Phase N/A

Blood Sample Collection in Subjects with Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer  

Phase N/A

People with HER2 negative advanced breast cancer are asked to participate in a research study being conducted by Queens Hospital Center.  

Phase N/A

People with non-small cell lung cancer are asked to participate in a research study being conducted by Montefiore Medical Center.   

Phase N/A

People with non-small cell lung cancer are asked to participate in a research study being conducted by Northwell Health.  

Phase N/A

People with non-small cell lung cancer are asked to participate in a research study being conducted by Montefiore Medical Center.  

Phase N/A

People with non-small cell lung cancer are asked to participate in a research study being conducted by Montefiore Medical Center.  

Phase N/A

A research study is evaluating an investigational vaccine compared to Prevnar 13™ for prevention of pneumococcal disease in adults 65 and older.  

Phase N/A